← Back to the feed

OOMNIUM AG

History from 24 Jun 2019

UID

CHE-362.911.768

Legal form

AG

Canton

ZH

Founded

24 Jun 2019

Amount raised

not in the SHAB

Lead investor

not in the SHAB

Record

1. SHAB published 27 Jun 2019 · legal date 24 Jun 2019

   Company formed

   Founded 24 Jun 2019

   SHAB HR01-1004660712 ↗

2. SHAB published 24 Jan 2022 · legal date 11 Jan 2022

   Capital increase

   Not assessed

   Paid in cash

   Nominal capital

   100’000 → 103’734

   Shares

   100’000 → 103’734

   New shares, % of post-step shares

   3.6% (3’734 new)

   Aktienkapital neu: CHF 103'734.00 [bisher: CHF 100'000.00]. Liberierung Aktienkapital neu: CHF 103'734.00 [bisher: CHF 50'000.00]. Aktien neu: 103'734 Namenaktien zu CHF 1.00 [bisher: 100'000 Namenaktien zu CHF 1.00].

   SHAB HR02-1005387453 ↗

3. SHAB published 16 Feb 2024 · legal date 26 Jan 2024

   Capital increase

   Not assessed

   Issued from conditional capital

   Nominal capital

   103’734 → 120’887

   Shares

   103’734 → 120’887

   New shares, % of post-step shares

   14.2% (17’153 new)

   Aktienkapital neu: CHF 120'887.00 [bisher: CHF 103'734.00]. Liberierung Aktienkapital neu: CHF 120'887.00 [bisher: CHF 103'734.00]. Aktien neu: 120'887 Namenaktien zu CHF 1.00 [bisher: 103'734 Namenaktien zu CHF 1.00].

   SHAB HR02-1005962830 ↗

4. SHAB published 4 Mar 2026 · legal date 25 Feb 2026

   Capital increase

   ○○○Capital increased · possible confirmation

   Issued from conditional capital

   Nominal capital

   120’887 → 133’545

   Shares

   120’887 → 133’545

   New shares, % of post-step shares

   9.5% (12’658 new)

   Aktienkapital neu: CHF 133'545.00 [bisher: CHF 120'887.00]. Liberierung Aktienkapital neu: CHF 133'545.00 [bisher: CHF 120'887.00]. Aktien neu: 133'545 Namenaktien zu CHF 1.00 [bisher: 120'887 Namenaktien zu CHF 1.00].

   • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
   • The company's purpose describes technology or life-sciences development.+0.5
   • Shares issued out of conditional capital, as when options are exercised.−1.0

   Classifier score 0.10 · likely-financing threshold 0.60 · not a calibrated probability

   SHAB HR02-1006585612 ↗

5. Announced 1 Apr 2026

   Round announced

   possible match · low match confidence

   Announcement ↗

6. SHAB published 2 Jul 2026 · legal date 26 Jun 2026

   Capital increase

   ●●○Likely financing

   Paid in cash

   Nominal capital

   133’545 → 165’693

   Shares

   133’545 → 165’693

   New shares, % of post-step shares

   19.4% (32’148 new)

   Aktienkapital neu: CHF 165'693.00 [bisher: CHF 133'545.00]. Liberierung Aktienkapital neu: CHF 165'693.00 [bisher: CHF 133'545.00]. Aktien neu: 165'693 Namenaktien zu CHF 1.00 [bisher: 133'545 Namenaktien zu CHF 1.00]. Partizipationskapital neu: CHF 3'668.00. Liberierung Partizipationskapital neu: CHF 3'668.00. Partizipationsscheine neu: 3'668 Namen-Partizipationsscheine zu CHF 1.00. Vinkulierung neu: Die Übertragbarkeit der Namenaktien und der Namenpartizipationsscheine ist nach Massgabe der Statuten beschränkt.

   • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
   • The company's purpose describes technology or life-sciences development.+0.5

   Classifier score 0.68 · likely-financing threshold 0.60 · not a calibrated probability

   SHAB HR02-1006694862 ↗

Published by 5 Jul 2026

Latest available record · 8 Oct 2026